Amicus' Acquiescence To Teva Reflects Power Of CREATES Act
Originator Agrees To provide Requested Quantities Of Galafold Samples
Teva has dismissed its suit against Amicus Therapeutics after the latter agreed to provide requested quantities of its Fabry disease treatment Galafold. The quick resolution of the complaint illustrates the success of the CREATES Act in halting the drug supply dispute but leaves some unanswered questions.
